Home > Products > CD3 & CD79B
> Anti-CD3 x Anti-CD79B Bispecific Antibody (IgG-IgG)
Anti-CD3 x Anti-CD79B Bispecific Antibody (IgG-IgG) (CAT#: BSIG-070)
Anti-CD3 x Anti-CD79B Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-CD79B parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
There are currently no customer reviews or questions for Anti-CD3 x Anti-CD79B Bispecific Antibody (IgG-IgG) (BSIG-070). Click the button below to contact us or submit your feedback about this product.